Coartem® Dispersible. An innovation in treating children with malaria.

Abstract

This fact sheet provides information about Coartem® Dispersible, a new paediatric formulation of Coartem® (artemether/lumefantrine) developed by MMV and Novartis. It is the first artemisinin-based combination therapy (ACT) developed especially for children with malaria.

Citation

Coartem® Dispersible. An innovation in treating children with malaria.

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.